Wibowo, Johan, Heriyanto, Rivaldo Steven, Wijovi, Felix, Halim, Devina Adella, Claudia, Claudia, Marcella, Elizabeth, Susanto, Billy, Indrawan, Michele, Heryadi, Nadia Khoirunnisa, Imanuelly, Michelle, Anurantha, Jonathan Juniard, Hariyanto, Timotius Ivan, Marcellin, Chintya, Sinaga, Terry Devita, Rizki, Saraswati Anindita, Sieto, Novia, Siregar, Jeremia Immanuel, Lugito, Nata Pratama Hardjo, and Kurniawan, Andree
Purpose: As coronavirus disease 2019 (COVID-19) continues to spread rapidly causing approximately 186 million confirmed cases around the world, the urgency to reach herd immunity through vaccination is increasing. However, vaccine safety is a top priority to limit the occurrence of adverse events. Henceforth, this study aims to recognize and perceive COVID-19 vaccine safety in Indonesia during the pandemic. Materials and Methods: This is a cross-sectional study and was conducted in Indonesia during the COVID-19 pandemic using an online survey of demographic information and a qualitative questionnaire. Responses were recorded and the association between demographic characteristics from survey questions was tested using chi-square with a risk estimate and 95% confidence interval. Results: A total of 311 participants from 33 out of 34 provinces in Indonesia participated in this study. Recorded responses showed multiple side effects of the COVID-19 vaccine both shortand long-term experienced by the participants. Significant associations were found between demographic factors and COVID-19 vaccine side effects such as female gender with shortterm puncture site (odds ratio [OR], 0.463; 95% confidence interval [CI], 0.263-0.816) and shortterm other reactions (OR, 0.463; 95% CI, 0.263-0.816), domicile outside Java island with longterm puncture site (OR, 4.219; 95% CI, 1.401-12.701) and immune reactions (OR, 3.375; 95% CI, 1.356-8.398), also between married marital status and long-term vagal reaction (OR, 4.655; 95% CI, 1.321-16.409). Conclusion: Gender, domicile and marital status factors were associated with COVID-19 vaccine side effects in Indonesian people. [ABSTRACT FROM AUTHOR]